| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... Nature 500 (7463), 415-421, 2013 | 9731 | 2013 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4340 | 2018 |
| The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours H Moch, AL Cubilla, PA Humphrey, VE Reuter, TM Ulbright European urology 70 (1), 93-105, 2016 | 4172 | 2016 |
| Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 3131 | 2016 |
| Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015 | 2605 | 2015 |
| The 2019 WHO classification of tumours of the digestive system ID Nagtegaal, RD Odze, D Klimstra, V Paradis, M Rugge, P Schirmacher, ... Histopathology 76 (2), 182, 2020 | 2603 | 2020 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2539 | 2018 |
| WHO Classification of Head and Neck Tumours AK El-Naggar, JKC Chan, JR Grandis, T Takata, PJ Slootweg Lyon: IARC Press, 2017 | 2435 | 2017 |
| Oncogenic signaling pathways in the cancer genome atlas Cell 173 (2), 321-337. e10, 2018 | 2396 | 2018 |
| The repertoire of mutational signatures in human cancer LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ... Nature 578 (7793), 94-101, 2020 | 2369 | 2020 |
| International network of cancer genome projects Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ... Nature 464 (7291), 993-998, 2010 | 2246 | 2010 |
| WHO Classification of Tumours of Endocrine Organs RV Lioyd, RY Osamura, G Kloppel, J Rosai WHO Classification of Tumours, 10, 81-91, 2017 | 2196* | 2017 |
| Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012 | 2179 | 2012 |
| Comprehensive characterization of cancer driver genes and mutations Cell 173 (2), 371-385. e18, 2018 | 2135 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer Cell 173 (2), 291-304. e6, 2018 | 1997 | 2018 |
| Pan-cancer analysis of whole genomes I The, TPCA of Whole, Genomes Consortium Nature 578 (7793), 82, 2020 | 1684* | 2020 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1553 | 2018 |
| Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017 | 1516 | 2017 |
| Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature, 2017 | 982 | 2017 |
| Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas Cell Reports 23 (1), 239-254. e6, 2018 | 900 | 2018 |
Angela ChouRoyal North Shore Hospital and Kolling Institute of Medical ResearchVerified email at sydney.edu.au
